transitioning from semaglutide to tirzepatide Switching Tirzepatide: A Provider's Guide Switch from Semaglutide to Tirzepatide:

Uh, its important to think about the route and tailoring the choice to the patient

Diabetes is caused either by the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced

Several studies have shown that GLP-1 agonists can improve menstrual cyclicity, reduce hyperandrogenism, and increase ovulation rates in women with PCOS

The most commonly reported adverse events (observed in greater than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease

GLP-1RAs thus prevent the occurrence of retinal damage associated with oxidative-stress-induced activation of glial cells and collectively foster a healthy retinal microenvironment by virtue of preventing cellular overexertion [94, 100]